EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)

$6.4 -0.15 (-2.2901%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 73

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) News Sources

Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting

22-04-2026

yahoo.com

external link

Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer

01-05-2026

yahoo.com

external link

Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW)

05-05-2026

yahoo.com

external link

Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week

06-05-2026

yahoo.com

external link

Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results

12-05-2026

yahoo.com

external link

Eupraxia Pharmaceuticals Q1 Loss Narrows

12-05-2026

yahoo.com

external link

Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

28-05-2026

yahoo.com

external link

Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders

19-06-2026

yahoo.com

external link

Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization

07-07-2026

yahoo.com

external link

Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth

13-07-2026

yahoo.com

external link

EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) Sentiment Trend

0 25 50 75 100 81 74 86 87 88 3 85 65 80 82 22-04-2026 01-05-2026 05-05-2026 06-05-2026 12-05-2026 28-05-2026 19-06-2026 07-07-2026 13-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) FAQs

toggle

What is the current price of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)?

The current price of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) is $6.4.


toggle

EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) absolute price change since previous trading day?

The absolute price change of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) since the previous trading day is $-0.15.


toggle

EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) percentage price change since previous trading day?

The percentage price change of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) since the previous trading day is -2.2901%.


toggle

What is the most recent average sentiment score for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)?

The most recent average sentiment score for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) is 73 out of 100.


toggle

What is the most recent average sentiment for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)?

The most recent sentiment for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) is .


SEC-8K** Filing Available For EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

CTXR (Citius Pharmaceuticals Inc)
RXRX (Recursion Pharmaceuticals Inc Cl A)
PCRX (Pacira Pharm Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.